GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (OTCPK:CLPBF) » Definitions » E10

Coloplast A/S (Coloplast A/S) E10 : $2.79 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Coloplast A/S E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Coloplast A/S's adjusted earnings per share data for the three months ended in Mar. 2024 was $0.812. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $2.79 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Coloplast A/S's average E10 Growth Rate was 5.00% per year. During the past 3 years, the average E10 Growth Rate was 11.20% per year. During the past 5 years, the average E10 Growth Rate was 11.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Coloplast A/S was 13.30% per year. The lowest was 8.20% per year. And the median was 11.55% per year.

As of today (2024-05-15), Coloplast A/S's current stock price is $128.20. Coloplast A/S's E10 for the quarter that ended in Mar. 2024 was $2.79. Coloplast A/S's Shiller PE Ratio of today is 45.95.

During the past 13 years, the highest Shiller PE Ratio of Coloplast A/S was 84.59. The lowest was 36.47. And the median was 59.10.


Coloplast A/S E10 Historical Data

The historical data trend for Coloplast A/S's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S E10 Chart

Coloplast A/S Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.86 2.22 2.55 2.33 2.67

Coloplast A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.73 2.76 2.67 2.86 2.79

Competitive Comparison of Coloplast A/S's E10

For the Medical Instruments & Supplies subindustry, Coloplast A/S's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast A/S's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's Shiller PE Ratio falls into.



Coloplast A/S E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Coloplast A/S's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.812/116.7000*116.7000
=0.812

Current CPI (Mar. 2024) = 116.7000.

Coloplast A/S Quarterly Data

per share eps CPI Adj_EPS
201406 0.673 99.700 0.788
201409 0.684 99.700 0.801
201412 0.620 99.400 0.728
201503 0.554 100.200 0.645
201506 0.500 100.300 0.582
201509 -1.005 100.200 -1.170
201512 0.565 99.800 0.661
201603 0.643 100.200 0.749
201606 0.695 100.600 0.806
201609 0.301 100.200 0.351
201612 0.632 100.300 0.735
201703 0.630 101.200 0.726
201706 0.648 101.200 0.747
201709 0.759 101.800 0.870
201712 0.703 101.300 0.810
201803 0.715 101.700 0.820
201806 0.701 102.300 0.800
201809 0.765 102.400 0.872
201812 0.711 102.100 0.813
201903 0.724 102.900 0.821
201906 0.759 102.900 0.861
201909 0.549 102.900 0.623
201912 0.762 102.900 0.864
202003 0.739 103.300 0.835
202006 0.705 103.200 0.797
202009 0.773 103.500 0.872
202012 0.872 103.400 0.984
202103 0.848 104.300 0.949
202106 0.953 105.000 1.059
202109 0.968 105.800 1.068
202112 0.860 106.600 0.941
202203 0.681 109.900 0.723
202206 0.861 113.600 0.884
202209 0.770 116.400 0.772
202212 0.756 115.900 0.761
202303 0.782 117.300 0.778
202306 0.870 116.400 0.872
202309 0.783 117.400 0.778
202312 0.789 116.700 0.789
202403 0.812 116.700 0.812

Add all the adjusted EPS together and divide 10 will get our e10.


Coloplast A/S  (OTCPK:CLPBF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Coloplast A/S's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=128.20/2.79
=45.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Coloplast A/S was 84.59. The lowest was 36.47. And the median was 59.10.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Coloplast A/S E10 Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast A/S (Coloplast A/S) Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (Coloplast A/S) Headlines

From GuruFocus

Coloplast A/S's Dividend Analysis

By GuruFocus Research 12-07-2023